Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Trace Biosciences has raised $150K in total funding. The most recent round was Series A. The last funding was announced in July 2026.
Trace Biosciences's investors include National Science Foundation, Advanced Research Projects Agency for Health, National Institutes of Health, SciFounders, AxoGen.
Trace Biosciences is headquartered in Beaverton, United States.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Trace Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trace Biosciences — Funding & Investors." VCBacked, July 29, 2026, https://www.vcbacked.co/company/trace-biosciences. Accessed August 13, 2026.
VCBacked. (2026). Trace Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/trace-biosciences
{{cite web |title=Trace Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/trace-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated